Back to Search
Start Over
Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support
- Source :
- Journal of the American College of Cardiology, Journal of the American College of Cardiology, 2018, 71 (19), pp.2106-2118. ⟨10.1016/j.jacc.2018.02.075⟩
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
-
Abstract
- International audience; Background: The main risk factor for bleeding in patients with continuous-flow mechanical circulatory support (CF-MCS) is the acquired von Willebrand factor (VWF) defect related to the high shear-stress forces developed by these devices. Although a higher bleeding rate has been reported in CF-MCS recipients who had reduced pulsatility, the relation between pulsatility and the VWF defect has never been studied.Objectives: The purpose of this study was to investigate the relation between pulsatility and VWF under CF-MCS.Methods: We assessed the effect of 2 CF-MCS on VWF multimer degradation in a mock circulatory loop (model 1). Using these devices, we investigated in a dose-effect model (model 2) 3 levels of pulsatility in 3 groups of swine. In a cross-over model (model 3), we studied the effects of sequential changes of pulsatility on VWF. We reported the evolution of VWF multimerization in a patient undergoing serial CF-MCS and/or pulsatile-MCS.Results: We demonstrated the proteolytic degradation of VWF multimers by high shear CF-MCS in a circulatory loop without pulsatility. We observed both in swine models and in a patient that the magnitude of the VWF degradation is modulated by the pulsatility level in the high shear-stress level condition, and that the restoration of pulsatility is a trigger for the endothelial release of VWF.Conclusions: We demonstrated that the VWF defect reflects the balance between degradation induced by the shear stress and the endothelial release of new VWF triggered by the pulsatility. This modulation of VWF levels could explain the relationship between pulsatility and bleeding observed in CF-MCS recipients. Preservation of pulsatility may be a new target to improve clinical outcomes of patients.
- Subjects :
- Male
Extracorporeal Circulation
congenital, hereditary, and neonatal diseases and abnormalities
medicine.medical_specialty
Swine
[SDV]Life Sciences [q-bio]
medicine.medical_treatment
Shock, Cardiogenic
Proteolytic degradation
arterial pulsatility
von Willebrand factor
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Von Willebrand factor
hemic and lymphatic diseases
Internal medicine
medicine
Extracorporeal membrane oxygenation
Animals
Humans
blood flow
Arterial Pressure
In patient
030212 general & internal medicine
Vwf multimers
mechanical circulatory support
biology
business.industry
Blood flow
Middle Aged
extracorporeal membrane oxygenation
bleeding
Pulsatile Flow
Circulatory system
biology.protein
Cardiology
Heart-Assist Devices
Stress, Mechanical
Cardiology and Cardiovascular Medicine
business
Biomarkers
circulatory and respiratory physiology
Subjects
Details
- ISSN :
- 07351097 and 15583597
- Volume :
- 71
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi.dedup.....2ec6e50421e10e74b680af3452d861b3
- Full Text :
- https://doi.org/10.1016/j.jacc.2018.02.075